STJ: St. Jude Medical, Inc. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
1990	48.25	34.50	-13.75	-28.50%
1991	34.50	55.50	21.00	60.87%
1992	55.50	42.00	-13.50	-24.32%
1993	42.00	26.50	-15.50	-36.90%
1994	26.50	39.75	13.25	50.00%
1995	39.75	64.50*	24.75	62.26%
1996	43.00	42.375	-0.625	-1.45%
1997	42.375	30.50	-11.875	-28.02%
1998	30.50	27.875	-2.625	-8.61%
1999	27.875	30.625	2.75	9.87%
2000	30.625	61.4375	30.8125	100.61%
2001	61.4375	77.65	16.2125	26.39%
2002	77.65	79.44*	1.79	2.31%
2003	39.72	61.35	21.63	54.46%
2004	61.35	83.86	22.51	36.69%
2005	41.93	50.20	8.27	19.72%
2006	50.20	36.56	-13.64	-27.17%
2007	36.56	40.64	4.08	11.16%
2008	40.64	32.96	-7.68	-18.90%
2009	32.96	36.78	3.82	11.59%
2010	36.78	42.75	5.97	16.23%
2011	42.75	34.30	-8.45	-19.77%
2012	34.30	36.14	1.84	5.36%
2013	36.14	61.95	25.81	71.42%
2014	61.95	65.03	3.08	4.97%
2015	65.03	61.77	-3.26	-5.01%
2016	61.77	80.19	18.42	29.82%
2017	80.19	96.882*	16.692	20.82%

*The 1995 ending price for St. Jude Medical has been adjusted for a 3 for 2 stock split.
*The 2002 ending price for St. Jude Medical has been adjusted for a 2 for 1 stock split.
*The 2004 ending price for St. Jude Medical has been adjusted for a 2 for 1 stock split.
*In 2017, Abbott Laboratories (ABT) completed its acquisition of St. Jude Medical (STJ) for $46.75 in cash and .8708 shares of ABT for every share of STJ held.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).